# A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis

> **NCT02144285** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 64 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** LY3113593
- **DRUG:** LY3113593
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02144285
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02144285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02144285, "A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02144285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*